Discovery's 'hospital rating' collides with clinicians by Bateman, Chris
January 2006, Vol. 96, No. 1  SAMJ
IZINDABA
14
Discovery Health’s new hospital rating 
index (HRI), a locally unprecedented 
Internet tool claiming to enable the 
tailoring of a patient’s needs to the ‘cost, 
quality and value’ offered by hospitals 
treating members, has run head-on into 
widespread resistance.
Using claims data on mortality, 
complications, and readmissions within 
30 days among their 1.8 million members, 
the medical aid has created a user-
friendly star-rated ‘hospital report card’ 
for virtually every major disease category 
(MDC) they fund. Only cancer, kidney 
disease and HIV/AIDS are excluded.
Hospitals as an institution are not rated 
but clusters of individual therapies are. 
This enables prospective patients, ‘in 
consultation with their doctors, to choose 
the hospital best suited to their needs’.
However, the South African Medical 
Association’s (SAMA’s) Private Practice 
Committee (PPC) and the Hospitals 
Association of South Africa (HASA) are 
taking the scheme with a large dose of 
salt. SAMA PPC chief, Dr Jan Talma, 
while supporting the ‘principle’ said 
any rating indices should be created 
by independent bodies with no vested 
interests and charged that the parameters 
used for rating failed to include accurate 
clinical data.
Expressing ‘grave concern’ about 
the potential (albeit unintentional) of 
misleading the public, Talma called for 
Discovery to remove the rating index, 
claiming it could be misinterpreted, thus 
damaging doctor-patient relationships. 
The index created the ‘perception’ of 
clinical outcomes when the ratings were 
primarily based on medical schemes 
claims data with indicators drawn mainly 
from financial and administrative data. ‘In 
light of this, the term “quality” can only 
be used by inference and not in absolute 
terms,’ warned Talma.
Discovery Health MD Barry Swartzberg 
still believes the cyber-tool that was 
2 years in the making and based on a 
successful international model, stands to 
change patient behaviour, improve service 
quality and lower traditionally high 
private hospital costs. ‘It’s an additional 
tool to use, as opposed to listening to 
your aunt on which hospital to go to,’ he 
stresses.
In addition to having control over 
their discretionary health spending, 
consumers should be able to benefit from 
the transparency the new index provided 
and should ‘get involved in their hospital 
spend as well,’ Swartzberg adds.
Ratings ‘flawed’ says HASA
However, Advocate Kurt Worrall-Clare, 
CEO of HASA, said that the ratings 
system, although a good idea, was 
‘flawed’. The way complications and 
readmissions were qualified failed to 
take account of patients presenting with 
pre-existing conditions, ignored the 
performance of the actual health care 
practitioner and penalised specialist 
hospitals. ‘Anything that encourages 
consumers to be more aggressive about 
quality should be commended, but this 
looks like a one size fits all approach 
which to my mind is not conducive to 
an accurate reading of the industry,’ he 
added.
He cited as an example the ‘average’ 
rating of Pretoria’s top specialist hospitals 
(heart and gynaecology). ‘Patients present 
with high or low blood pressure, we treat 
obese patients differently to others – all 
this needs to be taken into account. The 
practitioner often has no control over 
whether complications will result and 
sometimes re-admission may be indicated 
from the outset.’ 
Talma said that in the current era of 
medical super-specialisation, it was highly 
unlikely that all institutions would attract 
cases of similar complexity nor would 
they necessarily drive all costs. Above 
average costs should be interpreted in 
relation to the level of specialisation and 
the presence or absence of pre-existing co-
morbidities and risk factors.
Discovery Health’s head of clinical 
risk management, Dr Brian Ruff, said 
all scores were case-mix adjusted to the 
extent that the coded and administrative 
data allowed. This included pre-existing 
conditions and consequently did not 
compromise specialist hospitals. Ruff 
conceded that individual scores for 
practitioners were ‘not available at this 
stage’. He said Discovery Health had used 
a comprehensive ‘high-level approach’ 
that had the advantage of applying a 
standard methodology across the whole 
sector, thereby allowing comparisons.
The disadvantage of this was that it 
did not take the ‘few highly specific and 
unusual arrangements into account at this 
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stage’, but this anomaly was balanced 
by ‘useful information’ in the majority 
of cases. Ruff said only preventable 
complications were measured and not 
those that were an extension of the 
underlying pathology.
Worrall-Clare said distinguishing 
between cost and quality certainly 
allowed Discovery Health members 
to make qualified choices but asked 
that, where possible, ‘some indicator’ 
be included to evaluate the health 
profession. ‘While such an evaluation 
might be difficult, we believe it 
necessary in understanding the 
dynamics of the private hospital sector,’ 
he stressed.
Ruff said he believed that the HRI 
would result in hospital managers and 
doctors working together as a team 
to achieve quality as opposed to the 
traditional ‘purely independent’ way.
‘No consultation’
Responding to Worrall-Clare’s 
charge that Discovery Health had not 
discussed their product with HASA at 
any stage before its launch, Ruff said 
comprehensive briefings were made to 
the senior managements of NetCare, 
LifeHealth and Medi-Clinic.
Worrall-Clare said he had no problem 
with a mechanism to exert additional 
pressure on hospitals ‘to deal with 
the issue of costs’, but rating the vast 
majority as average was ‘manifestly 
unfair’ and ignored Discovery Health’s 
own Monitor research last year. This 
had rated South Africa’s private health 
care industry as the third best in the 
world. 
‘We have highly specialised hospitals 
and they’re certainly not average – like 
in the United States, where there is a 
move towards centres of excellence. You 
cannot ignore realities within the South 
African health system such as lifestyle 
diseases and the prevention of chronic 
conditions,’ he said.
Ruff responded that the HRI was 
an internal South African measure 
comparing quality against the measured 
average and not against any external 
benchmark. The idea was to promote 
continuous and repeated improvement, 
‘and not rest on our laurels – because 
international comparisons are 
flattering’.
Worrall-Clare noted that Discovery 
Health had set a 6-month revision date 
for their ratings system and said he 
hoped that HASA’s concerns would be 
addressed ‘through consultation and 
interaction with individual hospitals’.
A hospital rating index button on 
the Discovery website enables users to 
launch a search by inputting the major 
disease category and geographical 
region. The results list hospitals by star 
ratings (1 - 5) under headings of cost, 
quality and value for each disease and 
include admission volumes for each 
(‘experience rating’). Scores are not 
presented for a major disease category 
if the hospital has had less than 24 
admissions for an MDC over 2 years.
Touted as a ‘groundbreaking tool’, the 
website purports to give doctors greater 
discernment in helping patients tailor 
their needs to an ‘appropriate’ hospital 
– and influence ‘disproportionate’ 
private hospital consumption of 
available health care funds. 
Model under the spotlight
Swartzberg said that the index was 
created using data from 744 000 hospital 
admissions among its members during 
2003 and 2004 and had been scrutinised 
and approved by statistical and 
actuarial scientists at the University of 
the Witwatersrand.
‘We looked at the quality of outcomes 
of events – so far we’ve presented it to 
the South African Medical Association’s 
joint private practice committee and the 
GP equivalent, and they’re positive.’ 
However, the two SAMA groupings 
have requested further meetings to 
interrogate the model in greater detail.
Life Healthcare MD Michael 
Flemming questioned Discovery 
Health’s methodology, adding his 
voice to Worrall-Clare’s about how 
sick patients were upon admission 
and whether they had underlying 
conditions.
Swartzberg conceded while 
presenting the website to Izindaba 
that hospital groups had questioned 
their methodology – but not the 
concept. ‘They all want to know how 
we calculated the re-admissions and 
complications. We’re responding 
by changing and adapting and will 
continue to do so – basically we’re the 
only ones who have all the information 
at our disposal to do this kind of work,’ 
he said.
Discovery Health owns a quarter of 
the South African medical insurance 
market and covers an additional 100 000 
lives at the lower end, which they are 
aggressively pursuing using ‘KeyCare’, 
which uses hospital and non-hospital 
networks to make care more affordable.
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